Tesamorelin + Ipamorelin Blend Research Information
Dual Pathway Growth Hormone Secretagogue Blend
GHRH Analog + GHRP for Endocrine Research
Important: This information is for educational and research purposes only. Always consult with a qualified healthcare professional before use.
Contents
What is Tesamorelin + Ipamorelin Blend?
The Tesamorelin + Ipamorelin Blend is a synergistic combination of two growth hormone secretagogues: Tesamorelin, a 44-amino acid GHRH analog, and Ipamorelin, a pentapeptide GHRP .
This blend combines the benefits of both GHRH and GHRP pathways to enhance endogenous growth hormone release through dual mechanisms .
Mechanism of Action
The blend functions through dual pathways to support endocrine research:
GHRH Pathway
Tesamorelin stimulates GH release via GHRH receptor activation
GHRP Pathway
Ipamorelin stimulates GH release via ghrelin receptor agonism
Synergistic Effect
Dual pathway activation results in enhanced endogenous GH release
This combination provides a more physiological GH pulse pattern compared to either compound alone .
Research Applications
Endocrine Research
Growth hormone axis studies, pituitary function
Metabolic Research
Lipid metabolism, body composition studies
Aging Research
Age-related GH decline, sarcopenia studies
Recovery Studies
Tissue repair, muscle recovery research
Clinical Studies
Key Research Findings:
- Synergistic GH release through dual GHRH and GHRP pathways
- Tesamorelin approved for lipodystrophy treatment
- Ipamorelin shown to stimulate GH release without significant cortisol elevation
- Combination provides more physiological GH pulse pattern
Dosing Guide
Reconstitute your freeze-dried vial with 3mL bacteriostatic water. Units assume a standard U-100 insulin syringe (100 units = 1 mL).
Step 1: Select Vial Size
Step 2: Select Dose
Research protocols typically range from 500-2000 mcg daily, split AM/PM.
Vial Size
18mg Vial
Selected Dose
500 mcg
Doses per Vial
36 doses
Units on Syringe
8.3 units
Volume
0.083 mL
Protocol
Starting
Recommended Schedule
Split AM/PM - Subcutaneous Injection
Do not change your dose unless advised by a qualified professional.
Reconstitution Instructions
Add 3mL of bacteriostatic water to your freeze-dried vial and mix gently. After reconstitution, use the table below to draw your dose:
Vial Size
18mg vial with 3mL bac water (6 mg/mL)
| Dose | Units on Syringe | Volume (mL) | Protocol |
|---|
Always use a new sterile needle and syringe for each injection.
Safety & Precautions
Do not use if you:
- Are allergic to either component
- Are pregnant or breastfeeding
- Have active cancer
Warning: If you experience severe allergic reactions, difficulty breathing, or signs of anaphylaxis, seek immediate medical help.
References
- Tesamorelin + Ipamorelin Blend Research Overview. Peptide Sciences. 2025
- Growth Hormone Secretagogue Research. My Peptide. 2025
This information is for educational and research purposes only. Always consult with a qualified healthcare professional.
Last updated: August 2026